Skip to content
TrialScanner

NCT04088734

Gene Transfer Study of ABO-102 in Patients With Middle and Advanced Phases of MPS IIIA Disease

Phase 1/Phase 2TerminatedRARELeadABEOCollaborator

Registry record

Lead sponsor
Ultragenyx Pharmaceutical Inc
Conditions
MPS IIIA; Sanfilippo Syndrome; Sanfilippo A; Mucopolysaccharidosis III
Primary completion
Mar 10, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04088734 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04088734: Gene Transfer Study of... | TrialScanner